Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience

View ORCID ProfileMichael J Joyner, View ORCID ProfileJonathon W Senefeld, View ORCID ProfileStephen A Klassen, View ORCID ProfileJohn R Mills, View ORCID ProfilePatrick W Johnson, View ORCID ProfileElitza S Theel, View ORCID ProfileChad C Wiggins, View ORCID ProfileKatelyn A Bruno, View ORCID ProfileAllan M Klompas, View ORCID ProfileElizabeth R Lesser, View ORCID ProfileKatie L Kunze, View ORCID ProfileMatthew A Sexton, View ORCID ProfileJuan C Diaz Soto, View ORCID ProfileSarah E Baker, View ORCID ProfileJohn R.A. Shepherd, View ORCID ProfileNoud van Helmond, Camille M van Buskirk, View ORCID ProfileJeffrey L Winters, View ORCID ProfileJames R Stubbs, Robert F Rea, David O Hodge, View ORCID ProfileVitaly Herasevich, View ORCID ProfileEmily R Whelan, View ORCID ProfileAndrew J Clayburn, View ORCID ProfileKathryn F Larson, View ORCID ProfileJuan G Ripoll, View ORCID ProfileKylie J Andersen, View ORCID ProfileMatthew R Buras, Matthew N.P. Vogt, View ORCID ProfileJoshua J Dennis, View ORCID ProfileRiley J Regimbal, View ORCID ProfilePhilippe R Bauer, View ORCID ProfileJanis E Blair, View ORCID ProfileNigel S Paneth, View ORCID ProfileDeLisa Fairweather, R. Scott Wright, View ORCID ProfileRickey E Carter, View ORCID ProfileArturo Casadevall
doi: https://doi.org/10.1101/2020.08.12.20169359
Michael J Joyner
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael J Joyner
  • For correspondence: joyner.michael@mayo.edu
Jonathon W Senefeld
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathon W Senefeld
  • For correspondence: senefeld.jonathon@mayo.edu
Stephen A Klassen
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephen A Klassen
  • For correspondence: klassen.stephen@mayo.edu
John R Mills
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John R Mills
  • For correspondence: mills.john2@mayo.edu
Patrick W Johnson
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick W Johnson
  • For correspondence: johnson.patrick3@mayo.edu
Elitza S Theel
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elitza S Theel
  • For correspondence: theel.elitza@mayo.edu
Chad C Wiggins
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chad C Wiggins
  • For correspondence: wiggins.chad@mayo.edu
Katelyn A Bruno
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katelyn A Bruno
  • For correspondence: bruno.katelyn@mayo.edu
Allan M Klompas
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Allan M Klompas
  • For correspondence: klompas.allan@mayo.edu
Elizabeth R Lesser
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elizabeth R Lesser
  • For correspondence: lesser.elizabeth@mayo.edu
Katie L Kunze
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katie L Kunze
  • For correspondence: kunze.katie@mayo.edu
Matthew A Sexton
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew A Sexton
  • For correspondence: sexton.matthew@mayo.edu
Juan C Diaz Soto
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan C Diaz Soto
  • For correspondence: diaz.juan1@mayo.edu
Sarah E Baker
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah E Baker
  • For correspondence: baker.sarah@mayo.edu
John R.A. Shepherd
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John R.A. Shepherd
  • For correspondence: shepherd.john@icloud.com
Noud van Helmond
2 Cooper Medical School of Rowan University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Noud van Helmond
  • For correspondence: vanhelmond-noud@cooperhealth.edu
Camille M van Buskirk
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vanbuskirk.camille@mayo.edu
Jeffrey L Winters
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeffrey L Winters
  • For correspondence: winters.jeffrey@mayo.edu
James R Stubbs
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James R Stubbs
  • For correspondence: stubbs.james@mayo.edu
Robert F Rea
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rfrea@mayo.edu
David O Hodge
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hodge@mayo.edu
Vitaly Herasevich
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vitaly Herasevich
  • For correspondence: vitaly@mayo.edu
Emily R Whelan
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emily R Whelan
  • For correspondence: whelan.emily@mayo.edu
Andrew J Clayburn
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew J Clayburn
  • For correspondence: clayburn.andrew@mayo.edu
Kathryn F Larson
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathryn F Larson
  • For correspondence: larson.kathryn1@mayo.edu
Juan G Ripoll
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan G Ripoll
  • For correspondence: ripollsanz.juan@mayo.edu
Kylie J Andersen
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kylie J Andersen
  • For correspondence: andersen.kylie@mayo.edu
Matthew R Buras
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew R Buras
  • For correspondence: buras.matthew@mayo.edu
Matthew N.P. Vogt
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vogt.matthew@mayo.edu
Joshua J Dennis
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua J Dennis
  • For correspondence: dennis.joshua@mayo.edu
Riley J Regimbal
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Riley J Regimbal
  • For correspondence: regimbal.riley@mayo.edu
Philippe R Bauer
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Philippe R Bauer
  • For correspondence: bauer.philippe@mayo.edu
Janis E Blair
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Janis E Blair
  • For correspondence: blair.janis@mayo.edu
Nigel S Paneth
3 Michigan State University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nigel S Paneth
  • For correspondence: paneth@msu.edu
DeLisa Fairweather
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for DeLisa Fairweather
  • For correspondence: fairweather.delisa@mayo.edu
R. Scott Wright
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wright.scott@mayo.edu
Rickey E Carter
1 Mayo Clinic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rickey E Carter
  • For correspondence: carter.rickey@mayo.edu
Arturo Casadevall
4 Johns Hopkins School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arturo Casadevall
  • For correspondence: acasade1@jhu.edu
  • Abstract
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance: Passive antibody transfer is a longstanding treatment strategy for infectious diseases that involve the respiratory system. In this context, human convalescent plasma has been used to treat coronavirus disease 2019 (COVID-19), but the efficacy remains uncertain. Objective: To explore potential signals of efficacy of COVID-19 convalescent plasma. Design: Open-label, Expanded Access Program (EAP) for the treatment of COVID-19 patients with human convalescent plasma. Setting: Multicenter, including 2,807 acute care facilities in the US and territories. Participants: Adult participants enrolled and transfused under the purview of the US Convalescent Plasma EAP program between April 4 and July 4, 2020 who were hospitalized with (or at risk of) severe or life threatening acute COVID-19 respiratory syndrome. Intervention: Transfusion of at least one unit of human COVID-19 convalescent plasma using standard transfusion guidelines at any time during hospitalization. Convalescent plasma was donated by recently-recovered COVID-19 survivors, and the antibody levels in the units collected were unknown at the time of transfusion. Main Outcomes and Measures: Seven and thirty-day mortality. Results: The 35,322 transfused patients had heterogeneous demographic and clinical characteristics. This cohort included a high proportion of critically-ill patients, with 52.3% in the intensive care unit (ICU) and 27.5% receiving mechanical ventilation at the time of plasma transfusion. The seven-day mortality rate was 8.7% [95% CI 8.3%-9.2%] in patients transfused within 3 days of COVID-19 diagnosis but 11.9% [11.4%-12.2%] in patients transfused 4 or more days after diagnosis (p<0.001). Similar findings were observed in 30-day mortality (21.6% vs. 26.7%, p<0.0001). Importantly, a gradient of mortality was seen in relation to IgG antibody levels in the transfused plasma. For patients who received high IgG plasma (>18.45 S/Co), seven-day mortality was 8.9% (6.8%, 11.7%); for recipients of medium IgG plasma (4.62 to 18.45 S/Co) mortality was 11.6% (10.3%, 13.1%); and for recipients of low IgG plasma (<4.62 S/Co) mortality was 13.7% (11.1%, 16.8%) (p=0.048). This unadjusted dose-response relationship with IgG was also observed in thirty-day mortality (p=0.021). The pooled relative risk of mortality among patients transfused with high antibody level plasma units was 0.65 [0.47-0.92] for 7 days and 0.77 [0.63-0.94] for 30 days compared to low antibody level plasma units. Conclusions and Relevance: The relationships between reduced mortality and both earlier time to transfusion and higher antibody levels provide signatures of efficacy for convalescent plasma in the treatment of hospitalized COVID-19 patients. This information may be informative for the treatment of COVID-19 and design of randomized clinical trials involving convalescent plasma. Trial Registration: ClinicalTrials.gov Identifier: NCT04338360

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04338360

Funding Statement

This project has been funded in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority under Contract No. 75A50120C00096. Additionally, this study was supported in part by National Center for Advancing Translational Sciences (NCATS) grant UL1TR002377, National Heart, Lung, and Blood Institute (NHLBI) grant 5R35HL139854 (to MJJ), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5T32DK07352 (to JWS and CCW), Natural Sciences and Engineering Research Council of Canada (NSERC) PDF-532926-2019 (to SAK), National Institute of Allergy and Infectious Disease (NIAID) grants R21 AI145356, R21 AI152318 and R21 AI154927 (to DF), R01 AI152078 9 (to AC), National Heart Lung and Blood Institute RO1 HL059842 (to AC), National Institute on Aging (NIA) U54AG044170 (to SEB), Schwab Charitable Fund (Eric E Schmidt, Wendy Schmidt donors), United Health Group, National Basketball Association (NBA), Millennium Pharmaceuticals, Octapharma USA, Inc, and the Mayo Clinic.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Mayo Clinic IRB has approved this protocol (20-003312).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data not available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 12, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience
Michael J Joyner, Jonathon W Senefeld, Stephen A Klassen, John R Mills, Patrick W Johnson, Elitza S Theel, Chad C Wiggins, Katelyn A Bruno, Allan M Klompas, Elizabeth R Lesser, Katie L Kunze, Matthew A Sexton, Juan C Diaz Soto, Sarah E Baker, John R.A. Shepherd, Noud van Helmond, Camille M van Buskirk, Jeffrey L Winters, James R Stubbs, Robert F Rea, David O Hodge, Vitaly Herasevich, Emily R Whelan, Andrew J Clayburn, Kathryn F Larson, Juan G Ripoll, Kylie J Andersen, Matthew R Buras, Matthew N.P. Vogt, Joshua J Dennis, Riley J Regimbal, Philippe R Bauer, Janis E Blair, Nigel S Paneth, DeLisa Fairweather, R. Scott Wright, Rickey E Carter, Arturo Casadevall
medRxiv 2020.08.12.20169359; doi: https://doi.org/10.1101/2020.08.12.20169359
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience
Michael J Joyner, Jonathon W Senefeld, Stephen A Klassen, John R Mills, Patrick W Johnson, Elitza S Theel, Chad C Wiggins, Katelyn A Bruno, Allan M Klompas, Elizabeth R Lesser, Katie L Kunze, Matthew A Sexton, Juan C Diaz Soto, Sarah E Baker, John R.A. Shepherd, Noud van Helmond, Camille M van Buskirk, Jeffrey L Winters, James R Stubbs, Robert F Rea, David O Hodge, Vitaly Herasevich, Emily R Whelan, Andrew J Clayburn, Kathryn F Larson, Juan G Ripoll, Kylie J Andersen, Matthew R Buras, Matthew N.P. Vogt, Joshua J Dennis, Riley J Regimbal, Philippe R Bauer, Janis E Blair, Nigel S Paneth, DeLisa Fairweather, R. Scott Wright, Rickey E Carter, Arturo Casadevall
medRxiv 2020.08.12.20169359; doi: https://doi.org/10.1101/2020.08.12.20169359

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (415)
  • Dentistry and Oral Medicine (70)
  • Dermatology (48)
  • Emergency Medicine (144)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4861)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (676)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (630)
  • Health Policy (321)
  • Health Systems and Quality Improvement (206)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5343)
  • Intensive Care and Critical Care Medicine (331)
  • Medical Education (93)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (686)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (208)
  • Oncology (440)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (90)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (781)
  • Public and Global Health (1817)
  • Radiology and Imaging (325)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)